Pricing, Reimbursement, and Market Access expert with over 15 years’ experience in biopharmaceutical commercialization with global experience across healthcare systems and payer archetypes. Interim director level experience at multiple biopharma companies including: UCB (Immuno-dermatology global pricing director), Sanofi (Oncology, CVD, and MS EU Market Access Lead), Novartis (Ophthalmology Global Patient Access Director), and Takeda Oncology (Global Pricing and Market Access Lead). MSc in Finance from the London School of Economics and BSc in Pharmacology from University College London.